The design of non-peptide human bradykinin B2 receptor antagonists employing the benzodiazepine peptidomimetic scaffold
作者:Edward K. Dziadulewicz、Michael C. Brown、Andrew R. Dunstan、Wai Lee、Najeeb B. Said、Peter J. Garratt
DOI:10.1016/s0960-894x(99)00015-3
日期:1999.2
The Bradykinin B2 receptor antagonist HOE 140 (D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg) has been used as a template for the de novo design and synthesis of a small number of non-peptide lead compounds based on the 1,4-benzodiazepin-2-one framework. Two of the compounds have been found to exhibit moderate K(i) values of 8.9 and 9.2 microM at the human Bradykinin B2 receptor.
缓激肽B2受体拮抗剂HOE 140(D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg)已用作从头设计和少量合成的模板1,4-苯并二氮杂-2-酮骨架的非肽先导化合物。已发现其中两种化合物在人缓激肽B2受体上表现出8.9和9.2 microM的中等K(i)值。